- March 30, 2026
-
-
Loading
Loading
Oragenics, a publicly traded Tampa-based pharmaceutical company, says it will offer 1.4 million shares for $1.50 per share, seeking proceeds of $2.1 million to fund a promising brain-injury treatment.
